Skip to main content
. 2022 Dec 15;2022:3124122. doi: 10.1155/2022/3124122

Figure 2.

Figure 2

(a) Variations in the distribution and expression levels of chemokines across participants in The Cancer Genome Atlas (TCGA) cohort. (b) Variations in the distribution and expression levels of chemokine receptors in the TCGA cohort. (c) Variations in the IFN-γ score distribution across various subgroups in the TCGA cohort. (d) Variations in the lytic activity of the immune T cells exhibited across various subgroups. (e) Variations in angiogenesis scores recorded across various subgroups. (f) Variations in the expression and distribution of genes associated with immune checkpoints in TCGA cohort. One-way analysis of variance (ANOVA) was employed to conduct statistical tests to determine the significance level (p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001).